Subacute combined degeneration is a neurological disorder characterized by damage to the posterior and lateral columns of the spinal cord, most commonly resulting from vitamin B12 deficiency or impaired vitamin B12 function. It typically produces a combination of altered sensation, impaired balance, and weakness. “Combined” refers to involvement of both sensory and motor pathways, rather than to the coexistence of neurological disease and anemia. Neurological abnormalities can occur without anemia or an increased red blood cell size.
Anatomical and pathological features
The posterior columns carry information about vibration, joint position, and discriminative touch. Their involvement reduces awareness of limb position and can cause sensory ataxia: impaired coordination resulting from inadequate sensory feedback rather than primary dysfunction of the cerebellum.
The lateral columns contain the corticospinal tracts, which transmit signals involved in voluntary movement. Damage to these pathways can produce weakness, increased muscle tone, brisk tendon reflexes, and extensor plantar responses. Cervical and thoracic spinal cord regions are commonly affected.
The characteristic tissue changes include vacuolation and demyelination of spinal cord white matter. More advanced disease can involve axonal loss, which limits recovery. Peripheral nerve involvement frequently accompanies the spinal cord disorder, producing a combined myelopathy and neuropathy.
Causes and biological mechanisms
Vitamin B12 deficiency
Vitamin B12 is required for reactions involved in methionine synthesis and the conversion of methylmalonyl-CoA to succinyl-CoA. Deficiency disrupts these pathways and is associated with abnormal maintenance of myelin. The precise sequence connecting these biochemical abnormalities to the characteristic spinal cord lesions is not completely established.
Causes of vitamin B12 deficiency include:
- Impaired absorption, including autoimmune gastritis with intrinsic-factor deficiency, the process underlying pernicious anemia.
- Gastrointestinal disease or surgery, particularly conditions affecting the terminal small intestine, where vitamin B12 bound to intrinsic factor is absorbed, and operations that alter normal gastric or intestinal anatomy.
- Prolonged inadequate intake, including diets without sufficient vitamin B12-containing foods or supplementation.
- Medication-associated deficiency, including that associated with long-term metformin use or prolonged suppression of gastric acid.
Because substantial vitamin B12 stores are normally present in the body, deficiency caused by inadequate intake may take years to become clinically apparent.
Nitrous oxide exposure
Nitrous oxide can inactivate vitamin B12 and produce functional deficiency. Neurological disease may follow repeated recreational exposure; it can also occur after medical exposure, particularly in people with pre-existing deficiency.
In this setting, measured serum vitamin B12 may be within the laboratory reference range despite impaired vitamin activity. Nitrous oxide-associated disease often includes prominent peripheral nerve damage as well as spinal cord involvement.
Related nutritional myelopathies
Copper deficiency can produce a closely similar syndrome involving the posterior columns and corticospinal tracts. It is generally distinguished as copper-deficiency myelopathy rather than assumed to be vitamin B12-related subacute combined degeneration. Vitamin E deficiency and other nutritional disorders can also produce overlapping neurological findings.
Clinical manifestations
Symptoms usually develop progressively over weeks to months, although the pace varies. Common manifestations include tingling or numbness in the feet and hands, unsteady walking, and weakness.
Loss of vibration and joint-position sensation is characteristic. Balance may become particularly impaired in darkness or when visual cues are removed. A positive Romberg sign reflects this dependence on vision for postural stability.
Motor findings can include spasticity, brisk reflexes, and extensor plantar responses. However, accompanying peripheral neuropathy may reduce ankle reflexes, so examination findings are not always uniformly those of an upper motor neuron disorder. Severe disease can impair independent walking and may include bladder dysfunction.
Vitamin B12 deficiency can also cause cognitive, psychiatric, or optic nerve abnormalities. These may coexist with subacute combined degeneration but do not define the spinal cord syndrome.
Diagnosis
Diagnosis combines the clinical pattern, laboratory findings, exposure and dietary history, and, when appropriate, spinal imaging. No single finding establishes every case.
Laboratory assessment
Serum vitamin B12 is a standard initial measurement. Methylmalonic acid and homocysteine can provide evidence of functional deficiency when vitamin B12 results are borderline or inconsistent with the clinical findings. Their interpretation has limitations: methylmalonic acid can rise with impaired kidney function, while homocysteine is less specific and can also rise in folate deficiency.
A complete blood count may show macrocytic anemia, but normal hemoglobin and mean corpuscular volume do not exclude neurological vitamin B12 deficiency. Testing for intrinsic-factor antibodies can help identify autoimmune gastritis as the cause.
Imaging
Magnetic resonance imaging may show symmetric increased T2 signal in the posterior columns, sometimes extending into the lateral columns. On axial images, posterior-column involvement can form an “inverted V” pattern. These appearances are supportive rather than specific, and a normal scan does not exclude the disorder.
Differential diagnosis
The differential diagnosis includes copper-deficiency myelopathy, vitamin E deficiency, spinal cord compression, multiple sclerosis, and other inflammatory or infectious myelopathies. The distribution of abnormalities, blood tests, imaging, and clinical history help distinguish these conditions.
Treatment and prognosis
Established treatment consists of vitamin B12 replacement and management of the underlying cause. Parenteral replacement is commonly used initially when significant neurological involvement is present. The duration and route of subsequent replacement depend on the cause; irreversible malabsorption generally requires ongoing replacement. Nitrous oxide-associated disease also requires cessation of the exposure.
Folate alone does not correct vitamin B12-related neurological injury, although it may improve associated blood abnormalities. Consequently, improvement in anemia does not necessarily indicate correction of the neurological disorder.
Neurological recovery is variable and generally slower than hematological recovery. Sensory, gait, and strength improvements may continue over months, but longstanding axonal injury can leave persistent disability. Shorter symptom duration and less severe impairment at the start of treatment are associated with better recovery. Rehabilitation may address residual difficulties with walking, balance, and daily activities.